[1]
|
Louis, D.N., Perry, A., Reifenberger, G., et al. (2016) The 2016 World Health Organization Classification of Tumors of the Central Nervous System: A Summary. Acta Neuropathologica, 131, 803-820.
https://doi.org/10.1007/s00401-016-1545-1
|
[2]
|
Ostrom, Q. T., Gittleman, H., Stetson, L., et al. (2015) Current Understanding and Treatment of Gliomas. Springer International Publishing, Switzerland, 1-14.
|
[3]
|
Filley, A.C., Henriquez, M. and Dey, M. (2017) Recurrent Glioma Clinical Trial, CheckMate-143: The Game Is Not Over Yet. Oncotarget, 8, 91779-91794. https://doi.org/10.18632/oncotarget.21586
|
[4]
|
Lieberman, F. (2017) Glioblastoma Update: Molecular Biology, Diagnosis, Treatment, Response Assessment, and Translational Clinical Trials. F1000Research, 6, 1892. https://doi.org/10.12688/f1000research.11493.1
|
[5]
|
Stupp, R., Hegi, M.E., Mason, W.P., et al. (2009) Effects of Radiotherapy with Concomitant and Adjuvant Temozolomide versus Radiotherapy Alone on Survival in Glioblastoma in a Randomised Phase III Study: 5-Year Analysis of the EORTC-NCIC Trial. The Lancet Oncology, 10, 459-466. https://doi.org/10.1016/S1470-2045(09)70025-7
|
[6]
|
Hu, B., Wang, Q., Wang, Y.A., et al. (2016) Epigenetic Activation of WNT5A Drives Glioblastoma Stem Cell Differentiation and Invasive Growth. Cell, 167, 1281-1295. https://doi.org/10.1016/j.cell.2016.10.039
|
[7]
|
Tsutsumi, Y., Tsunoda, S., Kamada, H., et al. (1997) PEGylation of Interleukin-6 Effectively Increases Its Thrombopoietic Potency. Thrombosis and Haemostasis, 77, 168-173.
|
[8]
|
Gliadel (2018) Important Safety Imformation of GLIADEL Wafer. http://gliadel.com/hcp/index.php
|
[9]
|
Underwood, E. (2015) Ultrasound Therapies Target Brain Cancers and Alzheimer’s Disease. Science, 347, 1186-1187. https://doi.org/10.1126/science.347.6227.1186
|
[10]
|
Patel, M.M. and Patel, B.M. (2017) Crossing the Blood-Brain Barrier: Recent Advances in Drug Delivery to the Brain. Cns Drugs, 31, 109-133. https://doi.org/10.1007/s40263-016-0405-9
|
[11]
|
Zhang, Y. and Pardridge, W.M. (2006) Blood-Brain Barrier Targeting of BDNF Improves Motor Function in Rats with Middle Cerebral Artery Occlusion. Brain Research, 1111, 227-229. https://doi.org/10.1016/j.brainres.2006.07.005
|
[12]
|
Wang, Y.Y., Lui, P.C. and Li, J.Y. (2017) Receptor-Mediated Therapeutic Transport across the Blood-Brain Barrier. Immunotherapy, 1, 983-993. https://doi.org/10.2217/imt.09.75
|
[13]
|
魏晓丽. 稳定性多肽介导跨血脑屏障的脑胶质瘤双重靶向递药系统研究[D]: [博士学位论文]. 上海: 复旦大学药学院, 2014.
|
[14]
|
O’Donnell, K.A., Yu, D., Zeller, K.I., et al. (2006) Activation of Transferrin Receptor 1 by c-Myc Enhances Cellular Proliferation and Tumorigene-sis. Molecular and Cellular Biology, 26, 2373-2386.
|
[15]
|
Hogemann-Savellano, D., Bos, E., Blondet, C., et al. (2003) The Transfer-ring Receptor: A Potential Molecular Imaging Marker for Human Cancer. Neoplasia, 5, 495-506.
|
[16]
|
吴光勇. MIR分子影像学报告基因Tfr在胶质瘤中的表达及质粒的构建与鉴定[D]: [博士学位论文]. 湖南: 中南大学湘雅医院, 2007.
|
[17]
|
Chen, Y., Zhang, M., Jin, H., et al. (2017) Glioma Dual-Targeting Nanohybrid Protein Toxin Constructed by Intein-Mediated Site-Specific Ligation for Multistage Booster Delivery. Theranostics, 7, 3489-3503.
https://doi.org/10.7150/thno.20578
|
[18]
|
Liu, S., Guo, Y., Huang, R., et al. (2012) Gene and Doxorubicin Co-Delivery System for Targeting Therapy of Glioma. Biomaterials, 33, 4907-4916. https://doi.org/10.1016/j.biomaterials.2012.03.031
|
[19]
|
Wang, Z., Zhao, Y., Jiang, Y., et al. (2015) Enhanced Anti-Ischemic Stroke of ZL006 by T7-Conjugated PEGylated Liposomes Drug Delivery System. Scientific Reports, 5, Article No. 12651. https://doi.org/10.1038/srep12651
|
[20]
|
Zong, T., Mei, L., Gao, H., et al. (2014) Enhanced Glioma Targeting and Penetration by Dual-Targeting Liposome Co-Modified with T7 and TAT. Journal of Pharmaceutical Sciences, 103, 3891-3901.
https://doi.org/10.1002/jps.24186
|
[21]
|
Vu, K., Tham, R. and Uhrig, J. (2014) Invasion of the Central Nervous System by Cryp-tococcus Neoformans Requires a Secreted Fungal Metalloprotease. mBio, 5, e01101-e01114. https://doi.org/10.1128/mBio.01101-14
|
[22]
|
Demeule, M., Régina, A., Ché, C., et al. (2008) Identification and Design of Peptides as a New Drug Delivery System for the Brain. Journal of Pharmacology and Experimental Therapeutics, 24, 1064-1072.
|
[23]
|
Yang, Z.Z., Li, J.Q., Wang, Z.Z., et al. (2014) Tumor-Targeting Dual Peptides Modified Cationic Liposomes for Delivery of siRNA and Docetaxel to Gliomas. Biomaterials, 35, 5226-5239.
https://doi.org/10.1016/j.biomaterials.2014.03.017
|
[24]
|
Yainoy, S., Houbloyfa, P., Eiamphungporn, W., et al. (2014) Engineering of Chimeric Catalase-Angiopep-2 for Intracellular Protection of Brain Endothelial Cells against Oxidative Stress. International Journal of Biological Macromolecules, 68, 60-66. https://doi.org/10.1016/j.ijbiomac.2014.04.021
|
[25]
|
Sarkar, G., Curran, G.L., Sarkaria, G.N., et al. (2014) Peptide Carrier-Mediated Non-Covalent Delivery of Unmodified Cisplatin, Methotrexate and Other Agents via In-travenous Route to the Brain. PLoS ONE, 9, e97655.
https://doi.org/10.1371/journal.pone.0097655
|
[26]
|
Ben-Zvi, A., Lacoste, B., Kur, E., et al. (2014) MSFDA Is Critical for the Formation and Function of the Blood Brain Barrier. Nature, 509, 507-511. https://doi.org/10.1038/nature13324
|